Hemideina has raised funds via a private placement

Hemideina has raised US$7.4 million. The capital raised will be used to fund product development in preparation for the first human studies.

Hemideina is a Melbourne-based private company that is set to disrupt the cochlear implant market through its proprietary mechanical signal processing technology, the Hera wireless implant system. The company aims to provide a paradigm shift in hearing implant performance that will lead to increased access and adoption of treatment.

Oaklins’ team in Australia acted as lead manager in this transaction. The team has assisted Hemideina with fundraising since 2018 and is proud to support them on their mission to positively impact the lives of people with severe-to-profound hearing loss.

Service

Funding, debt advisory & ECM

Parties

“I’d like to extend my thanks to the team for managing the raise, as well as our team. The high-caliber work completed to date has built confidence around our technology with investors and continues to be the key to our success.”

Elizabeth Williams

CEO and co-founder, Hemideina

Talk to the deal team

Jonathan Tooth

Director

Melbourne, Australia
Oaklins Henslow

View profile Get in touch

Ryan Whitelegg

Managing Director

Melbourne, Australia
Oaklins Henslow

View profile Get in touch

Related deals

Dolmans Landscaping Group has welcomed Foreman Capital as a new shareholder to support further growth

Private Equity | Business Support Services | Construction & Engineering Services

Dolmans Landscaping Group has welcomed Foreman Capital as a new shareholder to support further growth

Dolmans Landscaping Group, a leading full-service provider of landscaping services, has welcomed Foreman Capital as a new shareholder. By partnering with Foreman Capital, which has extensive experience in building stronger companies in the maintenance of public spaces, Dolmans can accelerate its growth trajectory across core verticals and further professionalize the business.

Learn more

Backspin has completed a mandatory public tender offer for the shares of Spindox

Private Equity | TMT

Backspin has completed a mandatory public tender offer for the shares of Spindox

Backspin S.p.A. has completed a mandatory public tender offer for Spindox S.p.A.

Learn more

Rare Patient Voice has been acquired by Konovo

Healthcare | TMT

Rare Patient Voice has been acquired by Konovo

Rare Patient Voice has been acquired by Konovo, a technology-first healthcare intelligence company backed by Fraser Healthcare Partners.

Learn more